Effect of caffeine citrate in acute bronchiolitis symptoms of apnea in neonates and infants during the first three months of life

Dra Maria Luz Couce0 个研究点目标入组 96 人开始时间: 2016年2月3日最近更新: 2016年8月8日

适应症

试验速览

暂无简介。

•-Neonatos Aged between 0 and 90 days days diagnosed with acute respiratory syncytial virus bronchiolitis who present clinical symptoms of apnea
•-Informed Consent participation in the study, signed by parents or legal guardians of the newborn
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 105
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•-Which the family does not accept the informed consent
•- Patients who are being treated with caffeine
•- Patients with severe kidney or liver failure.
•- Caffeine increases heart rate, left ventricular volume and stroke volume output. Consequently newborns with known cardiovascular disease are excluded from this study.
•-Patients with hypoglycemia and / or electrolyte imbalance
•-Patients treated for gastroesophageal reflux
•- History of seizures
•-Patients with severe birth defects of the respiratory tract (severe tracheomalacia, tracheoesophageal fistula, diaphragmatic hernia, congenital lobar emphysema, cystic adenomatoid malformation)

发起方

Dra Maria Luz Couce